Donna M. Huryn is Professor in the Department of Pharmaceutical Sciences, and a PI of the University of Pittsburgh Chemical Diversity Center (UP-CDC). She also holds an Adjunct Professor appointment at the University of Pennsylvania’s Department of Chemistry. She received her B.A. from Cornell University, and Ph.D. in synthetic organic chemistry from Penn.
After graduate school, she joined the Chemistry Research Department at Hoffmann-La Roche, Inc, and contributed to drug discovery efforts in inflammation, HIV, and cancer. In 1997 she joined Wyeth Research, in the Chemical Sciences department. She held a number of positions there, including Director of CNS Medicinal Chemistry and Director of the Chemical Sciences Interface Department. Under her leadership, compounds entered clinical trials for asthma, Alzheimer’s disease, schizophrenia and depression. In 2004, she left the pharmaceutical industry to join academia, where her research interests include the identification of small molecule probes of biological systems, particularly those targetting cancer, infectious disease and neurodegenerative disorders.
Professor Huryn has served as a permanent member of several NIH Medical Chemistry A Study Section, and was a member of the NSF Committee of Visitors. She has held a number of elected positions within the American Chemical Society at both the local and national levels, and is an Associate Editor to ACS Medicinal Chemistry Letters, member of the Editorial Advisory Board of Organic Letters, member of the Editorial Board of Organic Reactions land a Fellow of the American Chemical Society